The Korean Society of Hematology Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2012
NCT01690065
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Alternative names

The Korean Society of Hematology, AML/MDS Working Party | The Korean Society of Hematology CML working party